Definitive Healthcare Corp.
DHNasdaqCIK 1861795TechnologyFiscal year ends Dec 31
Reports and events: 85 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0120:30 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001140361-26-038313 |
| 2026-09-0908:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-385950 |
| 2026-09-0209:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-379460 |
| 2026-09-0208:40 ET | SCHEDULE 13D | Ownership report, active investor | 0001193125-26-379428 |
| 2026-09-0208:31 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-379420 |
| 2026-09-0208:30 ET | SCHEDULE 13D | Ownership report, active investor | 0001140361-26-035412 |
| 2026-08-1016:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001193125-26-342488 |
| 2026-08-1016:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-342384 |
| 2026-06-2416:05 ET | 8-K | 3.01 Delisting notice | 0001193125-26-281037 |
| 2026-06-0516:05 ET | 8-K | 5.07 Shareholder vote results | 0001193125-26-259530 |
| 2026-05-0716:23 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001193125-26-212063 |
| 2026-05-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-211946 |
| 2026-04-2316:05 ET | DEF 14A | Proxy statementPeriod 2026-06-04 | 0001193125-26-173661 |
| 2026-04-0916:05 ET | 8-K | 1.02 Termination of a material agreement | 0001193125-26-149605 |
| 2026-04-0316:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-142104 |
| 2026-02-2616:21 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001193125-26-076782 |
| 2026-02-2616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-076609 |
| 2025-11-0616:27 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001193125-25-269681 |
| 2025-11-0616:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-269559 |
| 2025-08-0716:23 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0000950170-25-105071 |
| 2025-08-0716:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-105037 |
| 2025-07-2317:18 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-097966 |
| 2025-07-0116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-092187 |
| 2025-06-0616:07 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-083070 |
| 2025-05-0816:22 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-067044 |
| 2025-05-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-066957 |
| 2025-04-2316:11 ET | DEF 14A | Proxy statementPeriod 2025-06-05 | 0000950170-25-057364 |
| 2025-02-2716:22 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-029086 |
| 2025-02-2716:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-25-029049 |
| 2025-01-1616:12 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-25-006199 |
| 2024-11-0716:20 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0000950170-24-123385 |
| 2024-11-0716:14 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-24-123356 |
| 2024-10-0116:11 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-110816 |
| 2024-08-0516:25 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0000950170-24-090808 |
| 2024-08-0516:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-090774 |
| 2024-07-3016:30 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors | 0000950170-24-087900 |
| 2024-07-0816:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-24-082121 |
| 2024-05-2416:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000950170-24-064571 |
| 2024-05-0716:19 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0000950170-24-054539 |
| 2024-05-0716:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-054479 |
| 2024-04-0916:06 ET | DEF 14A | Proxy statementPeriod 2024-05-22 | 0001193125-24-090780 |
| 2024-02-2816:24 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-022134 |
| 2024-02-2816:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-022110 |
| 2024-01-1616:10 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-008562 |
| 2024-01-0408:59 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-001529 |
| 2023-11-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000950170-23-065480 |
| 2023-11-0216:23 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-058257 |
| 2023-11-0216:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-058213 |
| 2023-10-0516:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-052203 |
| 2023-09-0816:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-23-047275 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.